RX-1 Rhythm Express Remote Cardiac Monitoring System vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Powerful Medical

AI Verdict

Choose the RX-1 Rhythm Express Remote Cardiac Monitoring System if you require a physical, patient-worn patch device for continuous, multi-day ambulatory ECG monitoring and remote telemetry. Select PMcardio if you need a software-only, point-of-care AI platform to instantly analyze and interpret standard static ECGs for a wide range of acute cardiac conditions.

Choose RX-1 Rhythm Express Remote Cardiac Monitoring System if…

Choose the RX-1 Rhythm Express if you need a continuous, wearable patient monitoring solution that supports multi-day Holter, Event, and Mobile Cardiac Telemetry (MCT) tracking. It is ideal for cardiology practices requiring real-time, remote arrhythmia detection with advanced noise-suppression hardware and flexible billing models.

View RX-1 Rhythm Express Remote Cardiac Monitoring System →

Choose PMcardio if…

Choose PMcardio if you require an instant, point-of-care AI decision support tool to analyze standard ECG images and detect acute conditions like STEMI/OMI or reduced LVEF. It is best suited for emergency, internal medicine, or clinical teams needing rapid, expert-level diagnostic interpretations on a mobile or web platform.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RX-1 Rhythm Express Remote Cardiac Monitoring System PMcardio
Pricing Available via subscription, fee-for-service, or split-bill models. Freemium
Deployment Wearable device for patients, cloud-based platform for data management and review. Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers superior usability through its highly accessible mobile app (iOS and Android) and web platform, allowing clinicians to instantly scan and interpret standard 12-lead ECGs at the point of care [1.1.4]. In contrast, Tool A is a physical, patient-worn patch device that requires physical application, charging, and patient compliance, which inherently introduces more friction than a software-only mobile application.

Clinical Value

PMcardio

PMcardio provides extensive clinical value by detecting over 50 cardiac conditions (including STEMI/OMI and reduced LVEF) and has been rigorously validated in more than 25 clinical studies. While Tool A offers excellent continuous monitoring and noise suppression (MDSPu2122), PMcardio's broad diagnostic capabilities and deep clinical validation across multiple specialties make it the stronger clinical decision support tool.

Pricing & Value

PMcardio

PMcardio wins on pricing transparency and accessibility by offering a freemium model that includes a free tier with 5 ECG analyses per month, alongside a Pro plan for unlimited capacity. Tool A's pricing is more complex, requiring clinics to navigate subscription, fee-for-service, or split-bill models depending on device ownership and billing structures.

Enterprise Readiness

RX-1 Rhythm Express Remote Cardiac Monitoring System

Tool A is fully FDA-cleared and commercially available for remote cardiac monitoring in the United States. While PMcardio is CE-certified in Europe, it has not yet received FDA clearance for marketing in the USA (holding only an FDA Breakthrough Device Designation), making Tool A the ready choice for US-based healthcare enterprises.

Innovation

PMcardio

PMcardio showcases cutting-edge AI innovation with features like its 'Queen of Hearts' STEMI/OMI detection, 'LVsense' for reduced LVEF, and 'ECGxplain' which provides visual heatmaps for AI explainability. Tool A's innovation is centered around hardware-based noise suppression (MDSPu2122) and multi-mode monitoring, which is highly functional but less technologically advanced than PMcardio's deep-learning diagnostic suite.

Support & Docs

Tie

Both tools offer comprehensive support and documentation. Tool A provides highly detailed patient use guides, clinician manuals, and dedicated phone support for troubleshooting its physical monitoring hardware, while PMcardio provides extensive clinical research documentation, integration guides, and an online Trust Center for its software platform.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RX-1 Rhythm Express Remote Cardiac Monitoring System PMcardio
CE Certification Not specified Yes
Target Medical Specialties Cardiology Cardiology, Emergency Medicine, Internal Medicine
Hardware Specifications Continuous 2-channel ECG monitoring, up to 5 days battery life, water-resistant (IP64), compact design, built-in cellular connectivity Not specified
Clinical Capabilities Continuous ECG monitoring in MCT, Event, and Holter modes, automated arrhythmia detection, and patient-triggered event recording Interprets ECGs to assess over 50 cardiac conditions, including STEMI/OMI, rhythms, reduced LVEF, conduction disorders, and automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals

Videos

Demos, reviews, and walkthroughs featuring RX-1 Rhythm Express Remote Cardiac Monitoring System and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The RX-1 Rhythm Express is a wearable patch device designed for continuous, multi-day remote patient monitoring (MCT, Event, and Holter modes) with near real-time data transmission. PMcardio, on the other hand, is a point-of-care mobile and web platform designed for instant, retrospective AI interpretation of standard ECGs to detect over 50 cardiac conditions in seconds.
The RX-1 Rhythm Express is tailored specifically for Cardiology practices requiring extended outpatient ECG monitoring. PMcardio serves a broader clinical audience, including Cardiology, Emergency Medicine, and Internal Medicine, by providing rapid diagnostic support at the point of care.
The RX-1 Rhythm Express utilizes proprietary Multi-Domain Signal Processing (MDSPu2122) technology for advanced noise suppression and continuous 2-channel arrhythmia detection. PMcardio employs specialized AI models like Queen of Heartsu2122 for STEMI/OMI detection, LVsenseu2122 for reduced LVEF detection, and ECGxplainu2122 to provide visual heatmaps for AI explainability.
PMcardio is clinically validated in more than 25 studies and trusted by over 100,000 clinicians to detect 36 core diagnoses, including arrhythmias, conduction blocks, and chamber hypertrophies. The RX-1 Rhythm Express relies on its proprietary MDSPu2122 technology to suppress noise and deliver highly accurate, automated arrhythmia detection during continuous monitoring.
The RX-1 Rhythm Express offers flexible commercial models including subscription, fee-for-service, or split-billing where the clinic can bill globally or split professional/technical fees. PMcardio operates on a freemium model, providing a free tier with 5 monthly analyses and a Pro Plan for unlimited capacity, advanced measurements, and extended report history.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.